SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020016
Filing Date
2018-08-07
Accepted
2018-08-07 17:02:06
Documents
78
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cara-10q_20180630.htm 10-Q 2223867
2 EX-10.1 cara-ex101_642.htm EX-10.1 466146
3 EX-31.1 cara-ex311_300.htm EX-31.1 14658
4 EX-31.2 cara-ex312_299.htm EX-31.2 14532
5 EX-32.1 cara-ex321_298.htm EX-32.1 6752
  Complete submission text file 0001564590-18-020016.txt   9313676

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cara-20180630.xml EX-101.INS 2180302
7 XBRL TAXONOMY EXTENSION SCHEMA cara-20180630.xsd EX-101.SCH 53953
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20180630_cal.xml EX-101.CAL 51178
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20180630_def.xml EX-101.DEF 245462
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20180630_lab.xml EX-101.LAB 401319
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20180630_pre.xml EX-101.PRE 371538
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 18998908
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences